Prof. Dr. Max Reinshagen

  • Sprechstunde
  • Ermächtigungen
  • Auszeichnungen, Publikationen & Studien

Publikationen

Reinshagen M, Stallmach A.
Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial 
Z Gastroenterol. 2017 Aug;55(8):779-780

Wilcox MH, Gerding DN, Poxton IR, Kelly C, Nathan R, Birch T, Cornely OA, Rahav G, Bouza E, Lee C, Jenkin G, Jensen W, Kim YS, Yoshida J, Gabryelski L, Pedley A, Eves K, Tipping R, Guris D, Kartsonis N, Dorr MB; MODIFY I and MODIFY II Investigators.
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection. 
N Engl J Med. 2017 Jan 26;376(4):305-317

Hagel S, Fischer A, Ehlermann P, Frank T, Tueffers K, Sturm A, Link A, Demir M, Siebenhaar A, Storr M, Glueck T, Siegel E, Solbach P, Goeser F, Koelbel CB, Lohse A, Luebbert C, Kandzi U, Maier M, Schuerle S, Lerch MM, Tacke D, Cornely OA, Stallmach A, Vehreschild M; German Clinical Microbiome Study Group (GCMSG).
Fecal Microbiota Transplant in Patients With Recurrent Clostridium Difficile Infection. 
Dtsch Arztebl Int. 2016 Sep 5;113(35-36):583-9

Baumgart DC, Bokemeyer B, Drabik A, Stallmach A, Schreiber S; Vedolizumab Germany Consortium.
Vedolizumab induction therapy for inflammatory bowel disease in clinical practice--a nationwide consecutive German cohort study.
Aliment Pharmacol Ther. 2016 May;43(10):1090-102

Harbord M, Annese V, Vavricka SR, Allez M, Barreiro-de Acosta M, Boberg KM, Burisch J, De Vos M, De Vries AM, Dick AD, Juillerat P, Karlsen TH, Koutroubakis I, Lakatos PL, Orchard T, Papay P, Raine T, Reinshagen M, Thaci D, Tilg H, Carbonnel F; European Crohn’s and Colitis Organisation.
The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease. 
J Crohns Colitis. 2016 Mar;10(3):239-54.

Reinshagen M.
Regulation of T-cell trafficking in chronic inflammatory disease--far more complex!. 
Z Gastroenterol. 2015 Sep;53(9):1108

Miehlke S, Hruz P, Vieth M, Bussmann C, von Arnim U, Bajbouj M, Schlag C, Madisch A, Fibbe C, Wittenburg H, Allescher HD, Reinshagen M, Schubert S, Tack J, Müller M, Krummenerl P, Arts J, Mueller R, Dilger K, Greinwald R, Straumann A.
A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis.
Gut. 2015

Reinshagen M.
Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease.
Z Gastroenterol. 53(1):53, 2015

Raithel M, Hahn M, Donhuijsen K, Hagel AF, Nägel A, Rieker RJ, Neurath MF, Reinshagen M.
Eosinophilic gastroenteritis with refractory ulcer disease and gastrointestinal bleeding as a rare manifestation of seronegative gastrointestinal food allergy.
Nutr J. 2014 Sep 17;13:93, 2014

Leifeld L, Germer CT, Böhm S, Dumoulin FL, Häuser W, Kreis M, Labenz J, Lembcke B, Post S, Reinshagen M, Ritz JP, Sauerbruch T, Wedel T, von Rahden B, Kruis W.
S2k guidelines diverticular disease/diverticulitis

Hollerbach S, Reinshagen M, Seufferlein T, Bauer A, Landenberger M, Riemann JF.
First-degree relatives of colorectal cancer patients: how many can we protect?.
Z Gastroenterol. 2014 Mar;52(3):263.

von Boyen G, Reinshagen M.
The enteric glia - part of the puzzle in Crohn's disease?.
Z Gastroenterol. 2011, 49,1482-6.

Dignass A, Preiß JC, Aust DE, Autschbach F, Ballauff A, Barretton G, Bokemeyer B, Fichtner-Feigl S, Hagel S, Herrlinger KR, Jantschek G, Kroesen A, Kruis W, Kucharzik T, Langhorst J, Reinshagen M, Rogler G, Schleiermacher D, Schmidt C, Schreiber S, Schulze H, Stange E, Zeitz M, Hoffmann JC, Stallmach A.
Aktualisierte Leitlinie zur Diagnostik und Therapie der Colitis ulcerosa 2011 - Ergebnisse einer Evidenzbasierten Konsensuskonferenz - Updated German Guideline on Diagnosis and Treatment of Ulcerative Colitis, 2011
Z Gastroenterol. 2011, 49, 1276-1341.

Klaus J, Reinshagen M, Herdt K, Adler G, von Boyen GBT, von Tirpitz, C Intravenous ibandronate or sodium flouride – a 3.5 years study on bone density and fractures in Crohn´s disease patients with osteoporosis,
J. Gastrointestin Liver Dis. 2011,20, 141-148.

Klaus et al.
A single dose of i.v. zolendronate prevents glucocorticoid therapy associated bone loss in acute flare of Crohn´s disease, a randomized controlled trial.
Am. J. Gastroenterol. 2011, 106, 786-793

Teich et al.
Wahrnehmung der Schutzimpfung gegen die neue Grippe H1N1 durch Patienten mit Morbus Crohn und Colitis ulcerosa,
DMW (2011)

Klaus J, Reinshagen M, Herdt K, Schröter C , Adler G, von Boyen GBT, von Tirpitz C.
Bones and Crohn´s: No benefit of adding sodium flouride or ibandronate to calcium and Vitamin D.
World J. Gastroenterol.2011, 17, 334-342.

Holtmann MH, Krummenauer F, Claas C, Kremeyer K, Lorenz D, Rainer O, Vogel I, Böcker U, Böhm S, Büning C, Duchmann R, Gerken G, Herfarth H, Lügering N, Kruis W, Reinshagen M, Schmidt J, Stallmach A, Stein J, Sturm A, Galle PR, Hommes DW, D'Haens G, Rutgeerts P, Neurath MF.
Significant Differences Between Crohn's Disease and Ulcerative Colitis Regarding the Impact of Body Mass Index and Initial Disease Activity on Responsiveness to Azathioprine: Results from a European Multicenter Study in 1,176 Patients.
Dig Dis Sci. 2010, 55,1066-78.

Gert Van Assche, Axel Dignass, Walter Reinisch, C. Janneke van der Woude, Andreas Sturm, Martine De Vos, Mario Guslandi, Bas Oldenburg, Iris Dotan, Philippe Marteau, Alessandro Ardizzone, Daniel C. Baumgart, Geert D'Haens, Paolo Gionchetti, Francisco Portela, Boris Vucelic, Johan Söderholm, Johanna Escher, Sibylle Koletzko, Kaija-Leena Kolho, Milan Lukas, Christian Mottet, Herbert Tilg, Séverine Vermeire, Frank Carbonnel, Andrew Cole, Gottfried Novacek, Max Reinshagen, Epameinondas Tsianos, Klaus Herrlinger, Bas Oldenburg, Yoram Bouhnik, Ralf Kiesslich, Eduard Stange, Simon Travis, James Lindsay, for the European Crohn's and Colitis Organisation (ECCO).
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.
Journal of Crohn's and Colitis. 2010, 6, 63-101.

Klaus J, Spaniol U, Adler G, Mason RA, Reinshagen M, von Tirpitz C.
Small intestinal bacterial overgrowth mimicking acute flare as a pitfall in patients with Crohn's Disease.
BMC Gastroenterol. 2009 ;9:61.

Klaus J, Reinshagen M, Adler G, Boehm B, von Tirpitz C.
Bones and Crohn's: estradiol deficiency in men with Crohn's disease is not associated with reduced bone mineral density.
BMC Gastroenterol. 2008;8:48.

Reinshagen M.
Osteoporosis in inflammatory bowel disease
Journal of Crohn's and Colitis 2008, 2, 202-207

Hoffmann JC, Preiss JC, Autschbach F, Buhr HJ, Häuser W, Herrlinger K, Höhne W, Koletzko S, Krieglstein CF, Kruis W, Matthes H, Moser G, Reinshagen M, Rogler G, Schreiber S, Schreyer AG, Sido B, Siegmund B, Stallmach A, Bokemeyer B, Stange EF, Zeitz M.
Clinical practice guideline on diagnosis and treatment of Crohn's disease.
Z Gastroenterol. 2008 Sep;46(9):1094-146.

Hoffmann JC, Autschbach F, Bokemeyer B, Buhr HJ, Herrlinger K, Höhne W, Krieglstein C, Kruis W, Moser G, Preiss JC, Reinshagen M, Rogler G, Schreiber S, Schreyer AG, Siegmund B, Stallmach A, Stange EF, Zeitz M.
Short version of the updated German S3 (level 3) guideline on diagnosis and treatment of Crohn's disease.
Dtsch Med Wochenschr. 133(38):1924-9.

Reinshagen M, Schütz E, Armstrong VW, Behrens C, von Tirpitz C, Stallmach A, Herfarth H, Stein J, Bias P, Adler G, Shipkova M, Kruis W, Oellerich M, von Ahsen N.
6-thioguanine nucleotide-adapted azathioprine therapy does not lead to higher remission rates than standard therapy in chronic active crohn disease: results from a randomized, controlled, open trial.
Clin Chem. 2007 Jul;53(7):1306-14.

von Boyen GB, Steinkamp M, Reinshagen M, Schäfer KH, Adler G, Kirsch J.
Nerve growth factor secretion in cultured enteric glia cells is modulated by proinflammatory cytokines.
J Neuroendocrinol. 2006 Nov;18(11):820-5.

Holtmann MH, Krummenauer F, Claas C, Kremeyer K, Lorenz D, Rainer O, Vogel I, Böcker U, Böhm S, Büning C, Duchmann R, Gerken G, Herfarth H, Lügering N, Kruis W, Reinshagen M, Schmidt J, Stallmach A, Stein J, Sturm A, Galle PR, Hommes DW, D'Haens G, Rutgeerts P, Neurath MF.
Long-term effectiveness of azathioprine in IBD beyond 4 years: a European multicenter study in 1176 patients.
Dig Dis Sci. 2006 Sep;51(9):1516-24.

von Boyen GB, Steinkamp M, Geerling I, Reinshagen M, Schäfer KH, Adler G, Kirsch J.
Proinflammatory cytokines induce neurotrophic factor expression in enteric glia: a key to the regulation of epithelial apoptosis in Crohn's disease.
Inflamm Bowel Dis. 2006 May;12(5):346-54.

Reinshagen M.
Infliximab for ulcerative colitis.
N Engl J Med. 2006 Mar 30;354(13):1424-6.

Bregenzer N, Schäffler A, Gelbmann CM, Steinkamp M, Reinshagen M, Schölmerich J, Andus T.
Lack of correlation between the vitamin D receptor Fokl start codon polymorphism and bone mineral density in patients with Crohn's disease.
Exp Clin Endocrinol Diabetes. 2006 Jan;114(1):1-5.

Kruis W, Dignass A, Steinhagen-Thiessen E, Morgenstern J, Mössner J, Schreiber S, Vecchi M, Malesci A, Reinshagen M, Löfberg R.
Open label trial of granulocyte apheresis suggests therapeutic efficacy in chronically active steroid refractory ulcerative colitis.
World J Gastroenterol. 2005 Nov 28;11(44):7001-6.

Schröder O, Mickisch O, Seidler U, de Weerth A, Dignass AU, Herfarth H, Reinshagen M, Schreiber S, Junge U, Schrott M, Stein J.
Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study.
Am J Gastroenterol. 2005 Nov;100(11):2503-9.

von Ahsen N, Armstrong VW, Behrens C, von Tirpitz C, Stallmach A, Herfarth H, Stein J, Bias P, Adler G, Shipkova M, Oellerich M, Kruis W, Reinshagen M, Schütz E.
Association of inosine triphosphatase 94C>A and thiopurine S-methyltransferase deficiency with adverse events and study drop-outs under azathioprine therapy in a prospective Crohn disease study.
Clin Chem. 2005 Dec;51(12):2282-8.

Reinshagen M, Von Tirpitz C.
Diagnosis and management of osteoporosis in inflammatory bowel disease.
Minerva Med. 2004 Dec;95(6):481-7.

Reinshagen M, Fölsch UR.
Extraintestinal manifestations in ulcerative colitis.
Z Gastroenterol. 2004 Sep;42(9):1024-8.

Hoffmann JC, Zeitz M, Bischoff SC, Brambs HJ, Bruch HP, Buhr HJ, Dignass A, Fischer I, Fleig W, Fölsch UR, Herrlinger K, Höhne W, Jantschek G, Kaltz B, Keller KM, Knebel U, Kroesen AJ, Kruis W, Matthes H, Moser G, Mundt S, Pox C, Reinshagen M, Reissmann A, Riemann J, Rogler G, Schmiegel W, Schölmerich J, Schreiber S, Schwandner O, Selbmann HK, Stange EF, Utzig M, Wittekind C.
Diagnosis and therapy of ulcerative colitis: results of an evidence based consensus conference by the German society of Digestive and Metabolic Diseases and the competence network on inflammatory bowel disease.
Z Gastroenterol. 2004 Sep;42(9):979-83.

Kratzer W, Foeller T, Kaechele V, Reinshagen M, Tirpitz CV, Haenle MM.
Intestinal wall vascularisation in Crohn's disease.
Z Gastroenterol. 2004 Sep;42(9):973-8. German.

Herrlinger KR, Fellermann K, Fischer C, Kreisel W, Deibert P, Schoelmerich J, Fleig WE, Ruhl A, Reinshagen M, Greinwald R, Stange EF, Schwab M.
Thioguanine-nucleotides do not predict efficacy of tioguanine in Crohn's disease.
Aliment Pharmacol Ther. 2004 Jun 15;19(12):1269-76.

Ebinger M, Leidl R, Thomas S, Von Tirpitz C, Reinshagen M, Adler G, Konig HH.
Cost of outpatient care in patients with inflammatory bowel disease in a German University Hospital.
J Gastroenterol Hepatol. 2004 Feb;19(2):192-9.

von Boyen GB, Steinkamp M, Reinshagen M, Schäfer KH, Adler G, Kirsch J.
Proinflammatory cytokines increase glial fibrillary acidic protein expression in enteric glia.
Gut. 2004 Feb;53(2):222-8.

von Tirpitz C, Steder-Neukamm U, Glas K, Sander S, Ring C, Klaus J, Reinshagen M.
Osteoporosis in inflammatory bowel disease - results of a survey among members of the German Crohn's and Ulcerative Colitis Association.
Z Gastroenterol. 2003 Dec;41(12):1145-50.

Reinshagen M, von Tirpitz C.
Osteoporosis and other extraintestinal symptoms and complications of inflammatory bowel diseases.
Dig Dis. 2003;21(2):138-45.

von Tirpitz C, Epp S, Klaus J, Mason R, Hawa G, Brinskelle-Schmal N, Hofbauer LC, Adler G, Kratzer W, Reinshagen M.
Effect of systemic glucocorticoid therapy on bone metabolism and the osteoprotegerin system in patients with active Crohn's disease.
Eur J Gastroenterol Hepatol. 2003 Nov;15(11):1165-70.

von Tirpitz C, Reinshagen M.
Management of osteoporosis in patients with gastrointestinal diseases.
Eur J Gastroenterol Hepatol. 2003 Aug;15(8):869-76.

Schmidt T, Reinshagen M, Brambs HJ, Adler G, Rieber A, V Tirpitz C, Kratzer W.
Comparison of conventional enteroclysis, intestinal ultrasound and MRI-enteroclysis for determining changes in the small intestine and complications in patients with Crohn's disease.
Z Gastroenterol. 2003 Jul;41(7):641-8.

Reinshagen M, Hoffmann J, Adler G, Zeitz M; Arbeitsgruppe der Deutschen
Gesellschaft für Verdaunngs- und Stoffwechselkrankheiten. [Encoding patients with
chronic inflammatory bowel diseases according to the German DRG system]. Z
Gastroenterol. 2003 May;41(5):505-6.

Steinkamp M, Geerling I, Seufferlein T, von Boyen G, Egger B, Grossmann J, Ludwig L, Adler G, Reinshagen M.
Glial-derived neurotrophic factor regulates apoptosis in colonic epithelial cells.
Gastroenterology. 2003 Jun;124(7):1748-57.

Reinshagen M, Steinkamp M.
NGF---not just a nerve growth factor in the gut.
Am J Physiol Regul Integr Comp Physiol. 2003 May;284(5):R1322.

von Tirpitz C, Klaus J, Steinkamp M, Mason R, Kratzer W, Adler G, Rieber A, Reinshagen M.
Quantitative ultrasound of the proximal phalanges and dual-energy X-ray absorptiometry in Crohn's disease patients with osteopenia.
J Gastroenterol. 2003;38(3):238-43.

von Tirpitz C, Klaus J, Steinkamp M, Hofbauer LC, Kratzer W, Mason R, Boehm BO, Adler G, Reinshagen M.
Therapy of osteoporosis in patients with Crohn's disease: a randomized study comparing sodium fluoride and ibandronate.
Aliment Pharmacol Ther. 2003 Mar 15;17(6):807-16.

Herrlinger KR, Kreisel W, Schwab M, Schoelmerich J, Fleig WE, Ruhl A, Reinshagen M, Deibert P, Fellermann K, Greinwald R, Stange EF.
6-thioguanine--efficacy and safety in chronic active Crohn's disease.
Aliment Pharmacol Ther. 2003 Feb 15;17(4):503-8.

Adler G, Reinshagen M; German Society for Digestive and Metabolic Diseases.
Extraintestinal manifestations.
Z Gastroenterol. 2003 Jan;41(1):54-61.

Stange EF, Schreiber S, Fölsch UR, von Herbay A, Schölmerich J, Hoffmann J, Zeitz M, Fleig WE, Buhr HJ, Kroesen AJ, Moser G, Matthes H, Adler G, Reinshagen M, Stein J; German Society for Digestive and Metabolic Diseases.
Diagnostics and treatment of Crohn's disease -- results of an evidence-based consensus conference of the German Society for Digestive and Metabolic Diseases.
Z Gastroenterol. 2003 Jan;41(1):19-20.

König HH, Ulshöfer A, Gregor M, von Tirpitz C, Reinshagen M, Adler G, Leidl R.
Validation of the EuroQol questionnaire in patients with inflammatory bowel disease.
Eur J Gastroenterol Hepatol. 2002 Nov;14(11):1205-15.

Klaus J, Armbrecht G, Steinkamp M, Brückel J, Rieber A, Adler G, Reinshagen M, Felsenberg D, von Tirpitz C.
High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease.
Gut. 2002 Nov;51(5):654-8.

Heinzlmann M, Lang SM, Neynaber S, Reinshagen M, Emmrich J, Stratakis DF, Heldwein W, Wiebecke B, Loeschke K.
Screening for p53 and K-ras mutations in whole-gut lavage in chronic inflammatory bowel disease.
Eur J Gastroenterol Hepatol. 2002 Oct;14(10):1061-6.

von Boyen GB, Reinshagen M, Steinkamp M, Adler G, Kirsch J.
Enteric nervous plasticity and development: dependence on neurotrophic factors.
J Gastroenterol. 2002;37(8):583-8.

von Boyen GB, Reinshagen M, Steinkamp M, Adler G, Kirsch J.
Gut inflammation modulated by the enteric nervous system and neurotrophic factors.
Scand J Gastroenterol. 2002 Jun;37(6):621-5.

Reinshagen M, von Boyen G, Adler G, Steinkamp M.
Role of neurotrophins in inflammation of the gut.
Curr Opin Investig Drugs. 2002 Apr;3(4):565-8.

Rieber A, Nüssle K, Reinshagen M, Brambs HJ, Gabelmann A.
MRI of the abdomen with positive oral contrast agents for the diagnosis of inflammatory small bowel disease.
Abdom Imaging. 2002 Jul-Aug;27(4):394-9.

Rösch M, Leidl R, Tirpitz C, Reinshagen M, Adler G, König HH.
Cost measurement based on a cost diary in patients with inflammatory bowel disease.
Z Gastroenterol. 2002 Apr;40(4):217-28.

Rösch M, Leidl R, Thomas S, von Tirpitz C, Reinshagen M, Adler G, König HH.
Measurement of outpatient treatment costs of chronic inflammatory bowel diseases at a German university hospital.
Med Klin. 2002 Mar 15;97(3):128-36.

Kratzer W, von Tirpitz C, Mason R, Reinshagen M, Adler G, Möller P, Rieber A, Kächele V.
Contrast-enhanced power Doppler sonography of the intestinal wall in the differentiation of hypervascularized and hypovascularized intestinal obstructions in patients with Crohn's disease.
J Ultrasound Med. 2002 Feb;21(2):149-57.

Flämig G, Engele J, Geerling I, Pezeshki G, Adler G, Reinshagen M.
Neurotrophin and GDNF expression increases in rat adrenal glands during experimental colitis.
Neuro Endocrinol Lett. 2001 Dec;22(6):461-6.

von Tirpitz C, Kohn C, Steinkamp M, Geerling I, Maier V, Möller P, Adler G, Reinshagen M.
Lactose intolerance in active Crohn's disease: clinical value of duodenal lactase analysis.
J Clin Gastroenterol. 2002 Jan;34(1):49-53.

Steinkamp M, Reinshagen M.
Transforming growth factor-alpha in the regulation of enterocytic proliferation: part of a puzzle.
Eur J Gastroenterol Hepatol. 2001 Nov;13(11):1285-7.

Riedl S, Tandara A, Reinshagen M, Hinz U, Faissner A, Bodenmüller H, Buhr HJ, Herfarth C, Möller P.
Serum tenascin-C is an indicator of inflammatory bowel disease activity.
Int J Colorectal Dis. 2001 Sep;16(5):285-91.

Zeeh JM, Riley NE, Hoffmann P, Reinshagen M, Goebell H, Gerken G.
Expression of insulin-like growth factor binding proteins and collagen in experimental colitis in rats.
Eur J Gastroenterol Hepatol. 2001 Jul;13(7):851-8.

Dikopoulos N, Nüssler AK, Liptay S, Bachem M, Reinshagen M, Stiegler M, Schmid RM, Adler G, Weidenbach H.
Inhibition of nitric oxide synthesis by aminoguanidine increases intestinal damage in the acute phase of rat TNB-colitis.
Eur J Clin Invest. 2001 Mar;31(3):234-9.

Hoffmann P, Reinshagen M, Zeeh JM, Lakshmanan J, Wu VS, Goebell H, Gerken G, Eysselein VE.
Increased expression of epidermal growth factor-receptor in an experimental model of colitis in rats.
Scand J Gastroenterol. 2000 Nov;35(11):1174-80.

Rieber A, Aschoff A, Nüssle K, Wruk D, Tomczak R, Reinshagen M, Adler G, Brambs HJ.
MRI in the diagnosis of small bowel disease: use of positive and negative oral contrast media in combination with enteroclysis.
Eur Radiol. 2000;10(9):1377-82.

Rieber A, Wruk D, Potthast S, Nüssle K, Reinshagen M, Adler G, Brambs HJ.
Diagnostic imaging in Crohn's disease: comparison of magnetic resonance imaging and conventional imaging methods.
Int J Colorectal Dis. 2000 Jun;15(3):176-81.

Yardley G, Relf B, Lakshmanan J, Reinshagen M, Moore GP.
Expression of nerve growth factor mRNA and its translation products in the anagen hair follicle.
Exp Dermatol. 2000 Aug;9(4):283-9.

Reinshagen M, Rohm H, Steinkamp M, Lieb K, Geerling I, Von Herbay A, Flämig G, Eysselein VE, Adler G.
Protective role of neurotrophins in experimental inflammation of the rat gut.
Gastroenterology. 2000 Aug;119(2):368-76.

Weidenbach H, Leiz S, Nussler AK, Dikopoulos N, Bachem M, Buttenschoen K, Reinshagen M, Beger HG, Adler G, Schmid RM.
Disturbed bile secretion and cytochrome P450 function during the acute state of experimental colitis in rats.
J Hepatol. 2000 May;32(5):708-17.

Mayer D, Reinshagen M, Mason RA, Muche R, von Tirpitz C, Eckelt D, Adler G, Beckh K, Kratzer W.
Sonographic measurement of thickened bowel wall segments as a quantitative parameter for activity in inflammatory bowel disease.
Z Gastroenterol. 2000 Apr;38(4):295-300.

Rieber A, Wruk D, Nüssle K, Potthast S, Reinshagen M, Brambs HJ.
Current imaging in Crohn's disease: value of MRI compared with conventional proceedings.
Rontgenpraxis. 2000;52(10-12):378-83.

Reinshagen M, Geerling I, Eysselein VE, Adler G, Huff KR, Moore GP, Lakshmanan J.
Commercial recombinant human beta-nerve growth factor and adult ratdorsal root ganglia contain an identical molecular species of nerve growth factor prohormone.
J Neurochem. 2000 May;74(5):2127-33.

von Tirpitz C, Klaus J, Brückel J, Rieber A, Scholer A, Adler G, Böhm BO, Reinshagen M.
Increase of bone mineral density with sodium fluoride in patients with Crohn's disease.
Eur J Gastroenterol Hepatol. 2000 Jan;12(1):19-24.

 

Buchbeiträge und Bücher

Hoffmann,J.C., Krosen,A.J. und Klump,B. 2009.
Chronisch entzündliche Darmerkrankungen
Thieme Verlag Stuttgart, 2.Auflage 68-81.

Reinshagen,M. 2003.
Klinik des Morbus Crohn.
In CED-Manual. J.Hoffmann, Klump,B., and Kroesen,A.J., Editors. Blackwell, Berlin. (im Druck).

von Tirpitz,C., Reinshagen,M., and Adler,G. 2003.
Chronisch entzündliche Darmerkrankungen.
In Innere Medizin. M.Classen, Diehl,V., and Kochsiek,K., editors. Urban & Fischer, München, Jena. 1214-1223.

Reinshagen,M. 2002.
Azathioprin und 6-Mercaptopurin.
In Gastroenterologie Update 2002, Chronisch entzündliche Darmerkrankungen. A.Dignass and Stein,J., Editors. Springer Verlag, Berlin. 103-110.

Reinshagen,M. 2001.
Praxis der chronisch-entzündlichen Darmerkrankungen - Eine Fibel für den Hausarzt.
Uni-Med, Bremen. 1-94.

Reinshagen,M. 2000.
Ernährung bei CED - Was sind die Standards, was bringen neue Substrate?
In Chronisch entzündliche Darmerkrankungen. A.Dignass and Stein,J., Editors. Springer Verlag, Berlin. 201-205.

Adler,G. and Reinshagen,M. 2000.
Chronisch entzündliche Darmerkrankungen.
In Klinische Gastroenterologie und Stoffwechsel. G.Adler, Beglinger,C., Manns,M., Müller-Lissner,S., and Schmiegel,W., Editors. Springer, Berlin, Heidelberg, New York. 275-314.

Reinshagen,M., Rohm,H., Merkle,H., Geerling,I., Reimann,J., Lakshmanan,J., Eysselein,V.E., and Adler,G. 2000.
Differential expression of neurotrophins and their tyrosine kinase receptos in the inflamed colon of IL-2 k.o. and CD4+ repopulated SCID-mice suggest neuro-immune interactions.
In Neurogastroenterology - from the basics to the clinics. H.J.Krammer and Singer,M.V., Editors. Kluwer Academic, Dordrecht. 595-597.

Reinshagen,M., Rohm,H., Lakshmanan,J., and Eysselein,V.E. 1998.
Neuroimmune interactions in IBD.
In Innovative Concepts in Inflammatory Bowel Disease. J.Emmrich, Liebe,S., and Stange, E.F., Editors. Kluwer Academic Publishers, Lancaster. 43-46.

Eysselein,V.E. and Reinshagen,M. 1997.
Neuropeptides in inflammatory bowel disease.
In Inflammatory Bowel Disease - From Bench to Bedside. J.Schölmerich, Goebell,H., Andus,T., and Layer,P., Editors. Kluwer Academic publishers, Lancaster.

Reinshagen,M. and Adler,G. 1996.
Chronisch entzündliche Darmerkrankungen - Konservative Therapie.
In Gastroenterologische Notfalltherapie. G.J.Winkeltau and Lerch,M.M., Editors. Wissenschaftliche Verlagsgesellschaft, Stuttgart. 303-310.

Eysselein,V.E., Reinshagen,M., and Patel,A. 1993.
Sensory neuropeptides: inflammation and tissue healing.
In Inflammatory bowel disease, Pathophysiology as basis for treatment. J.Schölmerich, Kruis,W., Goebell,H., Hohenberger,W., and Gross,V., editors. Kluwer Academic Publishers, Dordrecht, Boston, London. 148-157.

Adler,G. and Reinshagen,M. 1990.
Influence of Intestinal Protease Inhibition on Pancreatic Feedback Regulation.
In Chronic Pancreatitis. H.G.Beger, Büchler,M., Ditschuneit,H., and Malfertheimer,P., editors. Springer, Berlin,Heidelberg. 178-184.